Skip to Content
Merck
CN

UHPLC Analysis of Conjugated Estrogens on Ascentis® Express C18

UHPLC Analysis of Conjugated Estrogens on Ascentis® Express C18 application for UHPLC

Materials

related product

Product No.
Description
Pricing

β-Estradiol

≥98%

β-Estradiol 3-(β-D-glucuronide) sodium salt

β-Estradiol 3-(β-D-glucuronide) 17-sulfate dipotassium salt

β-Estradiol 3-sulfate sodium salt

≥93%

Estrone 3-(β-D-glucuronide) sodium salt

Estriol

≥97%

β-Estradiol 3,17-disulfate dipotassium salt

≥95%

α-Estradiol

powder, ≥98% (TLC)

β-Estradiol 17-(β-D-glucuronide) sodium salt

Estriol 3-sulfate sodium salt

≥98% (TLC)

Estrone

≥99%

Estrone 3-sulfate sodium salt

contains ~35% Tris as stabilizer

Ascentis® Express C18, 2 μm UHPLC Column

2 μm particle size, L × I.D. 10 cm × 2.1 mm

CONDITIONS

column

Ascentis Express C18, 10 cm x 2.1 mm I.D., 2 μm particles (50813-U)

mobile phase

[A] 10 mM potassium phosphate, pH 7.0; [B] acetonitrile; [C] methanol

gradient

90:5:5 (A:B:C) to 75:20:5 (A:B:C) in 4.35 min; to 40:45:15 (A:B:C) in 6.75 min; to 90:5:5 (A:B:C) in 7 min

flow rate

0.6 mL/min

pressure

9500 psi (655 bar)

column temp.

35 °C

detector

UV, 220 nm

injection

2 μL

sample

50 μg/mL each in water:acetonitrile 60:40

Description

Analysis Note

The Ascentis Express C18 column provided efficient and rapid resolution of thirteen related estrogenic compounds. Ultra high purity solvents provided robust operation.

Legal Information

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany